Methylphenidate use in males with Duchenne muscular dystrophy and a comorbid attention-deficit hyperactivity disorder
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment of the CNS-related impairments consist of management through psycho-education and, occasionally, psychopharmacological therapy to address the psychiatric symptoms of DMD, such as ADHD, ASD and depression (Hendriksen et al., 2016; Lee et al., 2018; Lionarons et al., 2019; Darmahkasih et al., 2020; Noda et al., 2021).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Lionarons et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia
VAN der HEIJDEN, K. B., SMITS, M. G., VAN SOMEREN, E. J. W., RIDDERINKHOF, K. R., & GUNNING, W. B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246055.76167.0d · Cited by 378
ADHD Treatments, Sleep, and Sleep Problems: Complex Associations
Stein, M. A., Weiss, M., & Hlavaty, L. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0130-0 · Cited by 165
Tjon Pian Gi, C. V., Broeren, J. P. A., Starreveld, J. S., & A. Versteegh, F. G. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1207-x · Cited by 85
Lecendreux, M., & Cortese, S. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.12.1799 · Cited by 58
Groenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1301928 · Cited by 46
Research works printed but not linked: 21
- Moat, 2013, Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK), Eur J Hum Genet, 21, 1049, 10.1038/ejhg.2012.301 · DOI · Paper page
- Yiu, 2015, Duchenne muscular dystrophy, J Paediatr Child Health, 51, 759, 10.1111/jpc.12868 · DOI · Paper page
- Hendriksen, 2008, Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder, J Child Neurol, 23, 477, 10.1177/0883073807309775 · DOI · Paper page
- Snow, 2013, Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review, Neurosci Biobehav Rev, 37, 743, 10.1016/j.neubiorev.2013.03.016 · DOI · Paper page
- Pane, 2012, Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation, J Pediatr, 161, 705, 10.1016/j.jpeds.2012.03.020 · DOI · Paper page
- Anderson, 2002, Brain function in Duchenne muscular dystrophy, Brain, 125, 4, 10.1093/brain/awf012 · DOI · Paper page
- Polanczyk, 2007, The worldwide prevalence of ADHD: a systematic review and metaregression analysis, Am J Psychiatr, 164, 942, 10.1176/ajp.2007.164.6.942 · DOI · Paper page
- Young, 2008, Cognitive and psychological profile of males with Becker muscular dystrophy, J Child Neurol, 23, 155, 10.1177/0883073807307975 · DOI
- Birnkrant, 2018, Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan, Lancet Neurol, 17, 445, 10.1016/S1474-4422(18)30026-7 · DOI · Paper page
- Greenhill, 2001, Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults, J Am Acad Child Adolesc Psychiatry, 40, 1352, 10.1097/00004583-200111000-00020 · DOI
- Hendriksen, 2018, Brain-related comorbidities in boys and men with Duchenne Muscular Dystrophy: a descriptive study, Eur J Paediatr Neurol, 22, 488, 10.1016/j.ejpn.2017.12.004 · DOI
- Hendriksen, 2015, Diagnostic overshadowing in a population of children with neurological disabilities: a cross sectional descriptive study on acquired ADHD, Eur J Paediatr Neurol, 19, 521, 10.1016/j.ejpn.2015.04.004 · DOI
- Birnkrant, 2018, Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management, Lancet Neurol, 17, 347, 10.1016/S1474-4422(18)30025-5 · DOI · Paper page
- Huss, 2017, Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity, Neuropsychiatr Dis Treat, 13, 1741, 10.2147/NDT.S130444 · DOI
- Konrad, 2004, Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry, 43, 191, 10.1097/00004583-200402000-00015 · DOI · Paper page
- Lidzba, 2014, Pharmacotherapy of attention deficit in neurofibromatosis type 1: effects on cognition, Neuropediatrics, 45, 240, 10.1055/s-0034-1368117 · doi:10.1055/s-0034-1368117
- Mautner, 2002, Treatment of ADHD in neurofibromatosis type 1, Dev Med Child Neurol, 44, 164, 10.1017/S0012162201001876 · DOI · Paper page
- Chang, 2016, Diagnostic accuracy of rating scales for attention-deficit/hyperactivity disorder: a meta-analysis, Pediatrics, 137, 10.1542/peds.2015-2749 · DOI · Paper page
- Volkow, 2003, Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma, Psychopharmacology (Berl), 166, 264, 10.1007/s00213-002-1340-7 · DOI
- Hennissen, 2017, Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine, CNS Drugs, 31, 199, 10.1007/s40263-017-0410-7 · DOI · Paper page
- Waschbusch, 2008, Parent and teacher ratings on the Iowa Conners rating scale, J Psychopathol Behav Assess, 30, 180, 10.1007/s10862-007-9064-y · DOI
Cited by
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Lionarons, J. M., Hellebrekers, D. M. J., Klinkenberg, S., Faber, C. G., Vles, J. S. H., & Hendriksen, J. G. M.
- ORCID
- Faber, Catharina G.
- Venue
- European Journal of Paediatric Neurology
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 23
- Issue
- 1
- Pages
- 152-157
- ISSN
- 1090-3798
- Cited by
- 20
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Spieren voor Spieren Foundation (SvS15-)
- Duchenne Parent Project Netherlands (2016)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.